Clinical Trial Update: Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate [Phase 4]

View source ↗

Summary

A Phase 4 study in asthma patients comparing the combination inhaler Fluticasone Propionate/Salmeterol with Salmeterol Xinafoate, examining genetic factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)
• Salmeterol Xinafoate (salmeterol xinafoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED